Matthew Nachtrab, a resident of Florida, United States, has filed a Schedule 13G with the Securities and Exchange Commission (SEC) on August 16, 2024, indicating a significant ownership stake in Cassava Sciences Inc. According to the filing, Nachtrab owns 2,600,841 shares of Cassava Sciences' common stock, which represents 5.42% of the company's class of securities. The filing, made under Rule 13d-1(b), (c), or (d), specifies that Nachtrab has sole voting power over all the shares he owns, with no shared voting or dispositive power. The address of Cassava Sciences' principal executive offices is listed as 6801 N Capital of Texas Highway, Building 1; Suite 300, Austin, Texas, 78731. Nachtrab has certified that his ownership is not for the purpose of changing or influencing the control of Cassava Sciences, nor is it in connection with any transaction that has such purpose or effect.

Matthew Nachtrab, a resident of Florida, United States, has filed a Schedule 13G with the Securities and Exchange Commission (SEC) on August 16, 2024, indicating a significant ownership stake in Cassava Sciences Inc. According to the filing, Nachtrab owns 2,600,841 shares of Cassava Sciences' common stock, which represents 5.42% of the company's class of securities. The filing, made under Rule 13d-1(b), (c), or (d), specifies that Nachtrab has sole voting power over all the shares he owns, with no shared voting or dispositive power. The address of Cassava Sciences' principal executive offices is listed as 6801 N Capital of Texas Highway, Building 1; Suite 300, Austin, Texas, 78731. Nachtrab has certified that his ownership is not for the purpose of changing or influencing the control of Cassava Sciences, nor is it in connection with any transaction that has such purpose or effect.